Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, talked about the importance of having adequate support not only from clinical staff, but also emotional and moral support at home.
Having support at home when faced with a cancer diagnosis is "critical", said Susan Sabo-Wagner, MSN, RN, OCN, executive director of Clinical Strategy for Oncology Consultants.
Transcript
Can you speak to what makes for a successful at-home assessment, when people need care at home or support at home for cancer care, since so much care is moving back home?
Number one is to have someone who can support at home, be it a spouse, adult child, neighbor, or somebody. Even if you have a good home health care company or an aide that can go into the home, they can only be there however often their insurance will allow or even if they're paying privately, it is almost 100% necessary for at least somebody to be a caregiver. Of course, that depends on the patient [and] how well they do.
Even from a moral support or emotional support standpoint, it's really difficult to walk a full cancer diagnosis completely on your own without having someone that you can really depend on. There's definitely days where you don't feel well. My goodness, last week with my flu, I missed that I had somebody to feed my kids because there was a couple of days where I just couldn't. That's really what it's like for a cancer patient. There are days when you just can't, and it's either a physical feeling or it's an emotional feeling. To have somebody who can do those things, who can lift you up, that's critical.
Beyond that, we've made a lot of good connections with different companies throughout the city. We are in 12 locations in Houston for medical oncology, so we're all over the place. It's a big city with a lot of options, and we've been around and doing this for quite a long time. So, we know for the most part, who are the “good ones” and who we can really rely on. There's a lot of different insurance payers that we're dealing with; it's just as diverse within the payer market. So, this insurance company may not be able to have this particular home health, but we can work around in this way.
Our nurse navigators are very good about understanding because they both have worked in home health, as well. They understand how the insurance works, how home health works, how they can get the most benefit for each patient, how you write orders, and how you get things approved. They work very well with the home health companies that we’re mostly working with.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More